| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/30/2006 | CN1824263A Preparation method of medicine possessing spirit quieting brain supplementing action |
| 08/30/2006 | CN1824238A Quality control method of medicinal preparation for treating lypemania |
| 08/30/2006 | CN1824237A Medicine and food dual purpose Chinese medicinal product for improving sleep and its manufacturing method |
| 08/30/2006 | CN1824236A Medicine and food dual purpose Chinese medicinal product for regulating unquiet sleep and its manufacturing method |
| 08/30/2006 | CN1824234A Medicine and food dual purpose Chinese medicinal product for preventing and treating anypnia and its manufacturing method |
| 08/30/2006 | CN1824232A Medicine and food dual purpose Chinese medicinal nutritive product for preventing and treating alcoholism and its manufacturing method |
| 08/30/2006 | CN1824185A Chinese medicinal composition for treating agrypnia, functional gastricism and astriction and its preparation method |
| 08/30/2006 | CN1824174A Medicinal preparation made of gastrodia and uncaria |
| 08/30/2006 | CN1824172A Gastrodia freeze dried powder injection for intravenous injection and its preparation technology |
| 08/30/2006 | CN1824164A Medicine and food dual purpose Chinese medicinal nutritive product for preventing and treating pavor and its manufacturing method |
| 08/30/2006 | CN1824128A Semen locking medicinal preparation and its new preparation method |
| 08/30/2006 | CN1824075A Medicinal composition for treating hemicrania and its application |
| 08/30/2006 | CN1824069A Head wind pain preparation and its new preparation method |
| 08/30/2006 | CN1824036A Chinese medicinal composition for treating hemilateral headache and its preparation method |
| 08/30/2006 | CN1824028A Formula of Chinese medicine health protection wine |
| 08/30/2006 | CN1824026A Chinese medicine for improving memory and its preparation method |
| 08/30/2006 | CN1823992A Ginseny spleen invigorating preparation and its new preparation method |
| 08/30/2006 | CN1823963A Medicine for treating dampness damage and preparation method |
| 08/30/2006 | CN1823943A Preparation technology of Chinese medicine naodesheng concentrate pill |
| 08/30/2006 | CN1823940A Hydnocarpus anthelmintica preparation and preparation method |
| 08/30/2006 | CN1823938A Formula of spirit quieting medicine |
| 08/30/2006 | CN1823916A Extraction method of polygala refined total saponin |
| 08/30/2006 | CN1823911A Medicine and food dual purpose Chinese medicine for preventing and treating wind heat and headache and its manufacturing method |
| 08/30/2006 | CN1823909A Ultrasonic extraction technology of xiasangju |
| 08/30/2006 | CN1823899A Quality control method for dandengtongnao oral preparation |
| 08/30/2006 | CN1823891A Chinese medicinal composition for treating headache and its preparation method |
| 08/30/2006 | CN1823879A New use of mimosae pudicae herba medicine for treating spine nerve disease |
| 08/30/2006 | CN1823872A Biological preparation capable of improving cardio cerebral function |
| 08/30/2006 | CN1823851A Extract having analgesic action extracted from lard and its use |
| 08/30/2006 | CN1823815A Application of sodium sulfide vein injection liquid in preparation of medicine for treating sequela of cerebral embolism death |
| 08/30/2006 | CN1823803A Erigeron breviscapus injection preparation and its preparation method |
| 08/30/2006 | CN1823802A Gastrodin slow release preparation |
| 08/30/2006 | CN1823789A Oryzanol composition and its preparation method |
| 08/30/2006 | CN1823785A Application of tianeptine in preparation of medicine for treating or preventing MDMA nerve toxicity |
| 08/30/2006 | CN1823780A Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 08/30/2006 | CN1823776A Vinpocetine solid liposome nano-particle and its preparation technology |
| 08/30/2006 | CN1823769A Huperzine-A oral cavity disintegration tablet and its preparation method |
| 08/30/2006 | CN1823760A Use of artemisia apiacea kind medicine for treating gliosis |
| 08/30/2006 | CN1823759A Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells |
| 08/30/2006 | CN1823758A Compounds and methods of treating transplant rejection |
| 08/30/2006 | CN1823749A Sertraline salts and sustained-release dosage forms of sertraline |
| 08/30/2006 | CN1823729A Butyl benzene phthalein vein emulsion and its application |
| 08/30/2006 | CN1272328C Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 08/30/2006 | CN1272069C Stabilizing medicinal agent containing ciliary nerve nutritive factor analogue |
| 08/30/2006 | CN1272057C Chinese traditional medicine for treating facial paralysis, facial spasm and trifacial neuralgia |
| 08/30/2006 | CN1272049C Cigarette toxin resisting heath product preparation and its preparing process |
| 08/30/2006 | CN1272040C Paste form external use medicine for treating headache and its preparation |
| 08/30/2006 | CN1272018C Application of liquorice glycoside in preparing drugs for preventing and/or treating depression |
| 08/30/2006 | CN1272001C Aniracetam drop pills |
| 08/29/2006 | US7098337 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents |
| 08/29/2006 | US7098335 Pyrazolopyrimidine compositions |
| 08/29/2006 | US7098333 Parkinson's disease; antidepressants; cognition activators; attention deficit disorders; narcolepsy |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098322 Tumor necrosis factor and proteins with amino acid sequences to modulate signal passageways |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098236 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 08/29/2006 | US7098233 5-halo-tryptamine derivatives used as ligands on the 5-HT6 and/or 5-HT7 serotonin receptors |
| 08/29/2006 | US7098230 (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor |
| 08/29/2006 | US7098229 (+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 08/29/2006 | US7098223 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 08/29/2006 | US7098218 7,8,9, or 10-sulfamyl, (thio)phosphonyl, sulfonyl, or sulfonamido-naphth[2,1-f]isoquinolin-1,3-diones; drug screening; enzyme inhibitors; anticarcinogenic agents |
| 08/29/2006 | US7098216 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/29/2006 | US7098213 three-ring saturated N-heterocyclic compounds in combination with one or more antiviral or other agents; in immunotherapy |
| 08/29/2006 | US7098210 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient |
| 08/29/2006 | US7098207 Imidazotriazinones and the use thereof |
| 08/29/2006 | US7098204 Hymenialdisine or derivatives thereof in the manufacture of medicaments |
| 08/29/2006 | US7098203 and selective serotonin reuptake inhibitors; 4-benzyloxymethyl-4-phenylazepanes; antidepressants; anxiety |
| 08/29/2006 | US7098200 Analgesics |
| 08/29/2006 | US7098190 Formulations comprising antisense nucleotides to connexins |
| 08/29/2006 | US7098188 Alkali and alkaline earth metal salts of topiramate |
| 08/29/2006 | US7098027 Bone marrow or cord blood cells transplanted into rat animal model comprised of demyelinated axons in order to remyelinate defective nervous system tissues; gene therapy and neurodegenerative disorders |
| 08/29/2006 | US7097998 Aβ42 lowering agents |
| 08/29/2006 | US7097991 screening for an agent that modulates capsaicin receptor function |
| 08/29/2006 | CA2521980C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 08/29/2006 | CA2521958C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-pheyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) |
| 08/29/2006 | CA2402020C Pharmaceutical compositions |
| 08/29/2006 | CA2396738C Thiazole derivatives as active superoxide radical inhibitors |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/29/2006 | CA2342340C New sustained release oral formulations |
| 08/29/2006 | CA2268195C Azaheterocyclylmethyl derivatives of 2,3,8,9-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-one |
| 08/29/2006 | CA2233677C A novel combination of a .beta.-receptor blocker and an opioid |
| 08/29/2006 | CA2201785C New carboxylic acid derivatives, their preparation and their use |
| 08/29/2006 | CA2164842C Use of isovaleramide as a mild anxiolytic and mild sedative agent |
| 08/24/2006 | WO2006089053A2 Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
| 08/24/2006 | WO2006088765A1 Use of calcitonin and calcitonin-like peptides to treat and prevent multiple sclerosis |
| 08/24/2006 | WO2006088711A1 AZOLYLACYLGUANIDINES AS β-SECRETASE INHIBITORS |
| 08/24/2006 | WO2006088705A1 Terphenyl guanidines as [beta symbol] -secretase inhibitors |
| 08/24/2006 | WO2006088694A1 SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS |
| 08/24/2006 | WO2006088075A1 Pyridyl non-aromatic nitrogenated heterocyclic-1-carboxylate ester derivative |
| 08/24/2006 | WO2006088011A1 Inhibitor of plasminogen activator inhibitor-1 |
| 08/24/2006 | WO2006087732A1 An amorphous and three crystalline forms of rimonabant hydrochloride |
| 08/24/2006 | WO2006087639A1 Composition comprising ocaperidone |
| 08/24/2006 | WO2006087579A1 Treatment for neurodegeneration |
| 08/24/2006 | WO2006087577A2 Inhibition or treatment of dyskinesia |
| 08/24/2006 | WO2006087369A1 Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using them |
| 08/24/2006 | WO2006087306A2 Diazabicyclic aryl derivatives and their use as cholinergic ligands at the nicotinic acetylcholine receptors |
| 08/24/2006 | WO2006087305A1 Novel diazabicyclic aryl derivatives and their medical use |
| 08/24/2006 | WO2006087169A1 Compounds which potentiate glutamate receptor and uses thereof in medicine |
| 08/24/2006 | WO2006086986A1 Crystalline base of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |
| 08/24/2006 | WO2006086985A1 Tartrate and malate salts of trans-1-((1r,3s)-6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine |